The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
124982642 12498264 2 F 20160511 20160714 20160627 20160725 EXP JP-ROCHE-1782948 ROCHE 63.98 YR F Y 39.00000 KG 20160725 PH JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
124982642 12498264 1 PS HERCEPTIN TRASTUZUMAB 1 Intravenous drip DOSAGE IS UNCERTAIN. 103792 8 MG/KG SOLUTION FOR INFUSION QD
124982642 12498264 2 SS HERCEPTIN TRASTUZUMAB 1 Intravenous drip 103792 5.6 MG/KG SOLUTION FOR INFUSION Q3W
124982642 12498264 3 SS PERJETA PERTUZUMAB 1 Intravenous drip DOSAGE IS UNCERTAIN. 420MG/14ML 125409 840 MG SOLUTION FOR INFUSION QD
124982642 12498264 4 SS PERJETA PERTUZUMAB 1 Intravenous drip DOSAGE IS UNCERTAIN. 420MG/14ML 125409 420 MG SOLUTION FOR INFUSION QD
124982642 12498264 5 SS DOCETAXEL. DOCETAXEL 1 Intravenous drip Y 0 100 MG QD
124982642 12498264 6 SS DOCETAXEL. DOCETAXEL 1 Intravenous drip Y 0 70 MG QD
124982642 12498264 7 SS TS-1 GIMERACILOTERACILTEGAFUR 1 Oral Y 0 40 MG TABLET BID
124982642 12498264 8 SS OXYCONTIN OXYCODONE HYDROCHLORIDE 1 Oral OTHER PURPOSES: COMPLICATION (CANCER PAIN) Y 0 10 MG TABLET BID
124982642 12498264 9 SS OXINORM (JAPAN) OXYCODONE HYDROCHLORIDE 1 Oral TAKEN AS NEEDED 0 5 MG
124982642 12498264 10 SS FENTOS (JAPAN) FENTANYL 1 Transdermal THE FRACTIONATION DOSE FREQUENCY IS UNCERTAIN. ?DOSE INTERVAL UNCERTAINTY 0 4 MG
124982642 12498264 11 SS OXIFAST OXYCODONE 1 Intravenous (not otherwise specified) THE FRACTIONATION DOSE FREQUENCY IS UNCERTAIN. ?DOSE INTERVAL UNCERTAINTY Y 0 60 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
124982642 12498264 1 Breast cancer
124982642 12498264 2 Breast cancer
124982642 12498264 3 Breast cancer
124982642 12498264 5 Breast cancer
124982642 12498264 7 Breast cancer
124982642 12498264 8 Breast cancer
124982642 12498264 9 Cancer pain
124982642 12498264 10 Cancer pain
124982642 12498264 11 Cancer pain

Outcome of event

Event ID CASEID OUTC COD
124982642 12498264 LT

Reactions reported

Event ID CASEID DRUG REC ACT PT
124982642 12498264 Decreased appetite
124982642 12498264 Febrile neutropenia
124982642 12498264 Nausea
124982642 12498264 Vomiting

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
124982642 12498264 1 20160511 20160511 0
124982642 12498264 2 20160601 0
124982642 12498264 3 20160511 20160511 0
124982642 12498264 4 20160601 0
124982642 12498264 5 20160511 20160511 0
124982642 12498264 6 20160601 20160601 0
124982642 12498264 7 20160622 20160627 0
124982642 12498264 8 20160517 20160525 0
124982642 12498264 9 20160508 0
124982642 12498264 10 20160613 0
124982642 12498264 11 20160526 20160612 0